ctrl K

Price Alert

Tyra Biosciences Inc. (TYRA)

NASDAQ: TYRA · Real-Time Price · USD

10.73

0.03 (0.28%)

At close: Aug 15, 2025, 3:59 PM

10.73

0.00%

After-hours: Aug 15, 2025, 04:34 PM EDT

Tyra Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	91.97M	58.01M	251.21M	302.18M
Short-Term Investments	249.47M	145.46M	n/a	n/a
Long-Term Investments	n/a	n/a	1M	243K
Other Long-Term Assets	8.38M	6.03M	4.35M	555K
Receivables	2M	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	4.02M	8.2M	6.08M	1.88M
Total Current Assets	347.46M	211.67M	257.29M	304.06M
Property-Plant & Equipment	7.72M	8.15M	3.54M	2.09M
Goodwill & Intangibles	n/a	n/a	n/a	-505K
Total Long-Term Assets	16.09M	14.19M	8.89M	2.64M
Total Assets	363.56M	225.86M	266.18M	306.7M
Account Payables	590K	4.66M	1.15M	599K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	412K	n/a	140K	202K
Other Current Liabilities	13.59M	5.27M	1.42M	1.33M
Total Current Liabilities	14.59M	15.33M	5.7M	3.62M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3K	46K	169K	367K
Total Long-Term Liabilities	5.81M	6.26M	2.65M	1.35M
Total Liabilities	20.41M	21.59M	8.35M	4.96M
Total Debt	6.22M	6.5M	2.62M	1.18M
Common Stock	5K	4K	4K	4K
Retained Earnings	-251.31M	-164.83M	-95.7M	-40.37M
Comprehensive Income	770K	381K	-0.00	-306.7M
Shareholders Equity	343.15M	204.26M	-95.7M	301.74M
Total Investments	249.47M	145.46M	1M	243K